Tapewire

NYSE · USD

MRK

Merck & Co., Inc.

Export transactions ↓
Tapewire entity
2807
SEC CIK
0000310158
Parsed reports
1,951

Last 12 months

Inside the activity.

0 purchase rows · 35 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202502
Dec 202500
Jan 202600
Feb 2026016
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 2026017
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 04, 2021 Filed May 6, 2021 20:50 UTC
Zachary JenniferEVP, General Counsel
Tax withholdingCommon Stock 2,843 $75.98 $216,011.14
Disclosure

SEC source: 0001127602-21-015758 · form4.xml · nonDerivative · entry 2

Zachary Jennifer · CIK 0001737231 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,140.931

F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
May 04, 2021 Filed May 6, 2021 20:50 UTC
Zachary JenniferEVP, General Counsel
Exercise / conversionCommon Stock 5,772 $75.98 $438,556.56
Disclosure

SEC source: 0001127602-21-015758 · form4.xml · nonDerivative · entry 1

Zachary Jennifer · CIK 0001737231 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,983.931

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 04, 2021 Filed May 6, 2021 20:53 UTC
MIZELL STEVENEVP, Chief HR Officer
GrantStock Option (Right to Buy) · Derivative 64,286 $0.00 Strike: $75.99 $0.00
Disclosure

SEC source: 0001127602-21-015760 · form4.xml · derivative · entry 2

MIZELL STEVEN · CIK 0001189403 · EVP, Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,286

Underlying: Common Stock · 64,286 shares

Expires 2031-05-03

F2 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024.

Read SEC document
May 04, 2021 Filed May 6, 2021 20:55 UTC
Li Dean YExecutive VP & President, MRL
Exercise / conversionRestricted Stock Unit · Derivative 694 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-015763 · form4.xml · derivative · entry 4

Li Dean Y · CIK 0001837016 · Executive VP & President, MRL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 694 shares

Expires 2021-05-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

F4 · derivative.exercise_date: These restricted stock units vested and were distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021.

Read SEC document
May 04, 2021 Filed May 6, 2021 20:55 UTC
Li Dean YExecutive VP & President, MRL
GrantStock Option (Right to Buy) · Derivative 91,837 $0.00 Strike: $75.99 $0.00
Disclosure

SEC source: 0001127602-21-015763 · form4.xml · derivative · entry 3

Li Dean Y · CIK 0001837016 · Executive VP & President, MRL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,837

Underlying: Common Stock · 91,837 shares

Expires 2031-05-03

F2 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024.

Read SEC document
May 04, 2021 Filed May 6, 2021 20:55 UTC
Li Dean YExecutive VP & President, MRL
Tax withholdingCommon Stock 238 $75.98 $18,083.24
Disclosure

SEC source: 0001127602-21-015763 · form4.xml · nonDerivative · entry 2

Li Dean Y · CIK 0001837016 · Executive VP & President, MRL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,309.914

F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
May 04, 2021 Filed May 6, 2021 20:55 UTC
Li Dean YExecutive VP & President, MRL
Exercise / conversionCommon Stock 694 $75.98 $52,730.12
Disclosure

SEC source: 0001127602-21-015763 · form4.xml · nonDerivative · entry 1

Li Dean Y · CIK 0001837016 · Executive VP & President, MRL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,547.914

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 04, 2021 Filed May 6, 2021 21:01 UTC Exercise / conversionRestricted Stock Unit · Derivative 1,039 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-015766 · form4.xml · derivative · entry 4

Litchfield Caroline · CIK 0001854928 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,039 shares

Expires 2021-05-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

F4 · derivative.exercise_date: These restricted stock units vested and were distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021.

Read SEC document
May 04, 2021 Filed May 6, 2021 21:01 UTC GrantStock Option (Right to Buy) · Derivative 67,347 $0.00 Strike: $75.99 $0.00
Disclosure

SEC source: 0001127602-21-015766 · form4.xml · derivative · entry 3

Litchfield Caroline · CIK 0001854928 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,347

Underlying: Common Stock · 67,347 shares

Expires 2031-05-03

F2 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024.

Read SEC document
May 04, 2021 Filed May 6, 2021 21:01 UTC Tax withholdingCommon Stock 489 $75.98 $37,154.22
Disclosure

SEC source: 0001127602-21-015766 · form4.xml · nonDerivative · entry 2

Litchfield Caroline · CIK 0001854928 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,741.1241

F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
May 04, 2021 Filed May 6, 2021 21:01 UTC Exercise / conversionCommon Stock 1,039 $75.98 $78,943.22
Disclosure

SEC source: 0001127602-21-015766 · form4.xml · nonDerivative · entry 1

Litchfield Caroline · CIK 0001854928 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,230.1241

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 04, 2021 Filed May 6, 2021 21:02 UTC
Karachun Rita ASr. VP Fince-Global Controller
Exercise / conversionRestricted Stock Unit · Derivative 1,212 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-015768 · form4.xml · derivative · entry 5

Karachun Rita A · CIK 0001601572 · Sr. VP Fince-Global Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,212 shares

Expires 2021-05-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

F5 · derivative.exercise_date: These restricted stock units vested and were distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021.

Read SEC document
May 04, 2021 Filed May 6, 2021 21:02 UTC
Karachun Rita ASr. VP Fince-Global Controller
GrantRestricted Stock Unit · Derivative 2,764 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-015768 · form4.xml · derivative · entry 4

Karachun Rita A · CIK 0001601572 · Sr. VP Fince-Global Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,764

Underlying: Common Stock · 2,764 shares

Expires 2024-05-04

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

F4 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024.

Read SEC document
May 04, 2021 Filed May 6, 2021 21:02 UTC
Karachun Rita ASr. VP Fince-Global Controller
GrantStock Option (Right to Buy) · Derivative 21,429 $0.00 Strike: $75.99 $0.00
Disclosure

SEC source: 0001127602-21-015768 · form4.xml · derivative · entry 3

Karachun Rita A · CIK 0001601572 · Sr. VP Fince-Global Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,429

Underlying: Common Stock · 21,429 shares

Expires 2031-05-03

F2 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024.

Read SEC document
May 04, 2021 Filed May 6, 2021 21:02 UTC
Karachun Rita ASr. VP Fince-Global Controller
Tax withholdingCommon Stock 416 $75.98 $31,607.68
Disclosure

SEC source: 0001127602-21-015768 · form4.xml · nonDerivative · entry 2

Karachun Rita A · CIK 0001601572 · Sr. VP Fince-Global Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,798.972

F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
May 04, 2021 Filed May 6, 2021 21:02 UTC
Karachun Rita ASr. VP Fince-Global Controller
Exercise / conversionCommon Stock 1,212 $75.98 $92,087.76
Disclosure

SEC source: 0001127602-21-015768 · form4.xml · nonDerivative · entry 1

Karachun Rita A · CIK 0001601572 · Sr. VP Fince-Global Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,214.972

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 04, 2021 Filed May 6, 2021 21:04 UTC
Williams David MichaelEVP,Chief Info&Digital Officer
Exercise / conversionRestricted Stock Unit · Derivative 417 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-015770 · form4.xml · derivative · entry 4

Williams David Michael · CIK 0001820958 · EVP,Chief Info&Digital Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 417 shares

Expires 2021-05-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

F4 · derivative.exercise_date: These restricted stock units vested and were distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021.

Read SEC document
May 04, 2021 Filed May 6, 2021 21:04 UTC
Williams David MichaelEVP,Chief Info&Digital Officer
GrantStock Option (Right to Buy) · Derivative 33,673 $0.00 Strike: $75.99 $0.00
Disclosure

SEC source: 0001127602-21-015770 · form4.xml · derivative · entry 3

Williams David Michael · CIK 0001820958 · EVP,Chief Info&Digital Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,673

Underlying: Common Stock · 33,673 shares

Expires 2031-05-03

F2 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024.

Read SEC document
May 04, 2021 Filed May 6, 2021 21:04 UTC
Williams David MichaelEVP,Chief Info&Digital Officer
Tax withholdingCommon Stock 143 $75.98 $10,865.14
Disclosure

SEC source: 0001127602-21-015770 · form4.xml · nonDerivative · entry 2

Williams David Michael · CIK 0001820958 · EVP,Chief Info&Digital Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,518.757

F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
May 04, 2021 Filed May 6, 2021 21:04 UTC
Williams David MichaelEVP,Chief Info&Digital Officer
Exercise / conversionCommon Stock 417 $75.98 $31,683.66
Disclosure

SEC source: 0001127602-21-015770 · form4.xml · nonDerivative · entry 1

Williams David Michael · CIK 0001820958 · EVP,Chief Info&Digital Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,661.757

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 04, 2021 Filed Nov 4, 2021 20:21 UTC
Clyburn FrankEVP & Pres ? Human Health
GrantRestricted Stock Unit · Derivative 39,479 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-028389 · form4.xml · derivative · entry 1

Clyburn Frank · CIK 0001763963 · EVP & Pres ? Human Health

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,479

Underlying: Common Stock · 39,479 shares

Expires 2024-05-04

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

F2 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in one installment on 5/4/2024.

Read SEC document
May 04, 2021 Filed Nov 4, 2021 20:24 UTC
DeLuca Richard R.EVP&Pres, Merck Animal Heallth
GrantRestricted Stock Unit · Derivative 26,319 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-028391 · form4.xml · derivative · entry 1

DeLuca Richard R. · CIK 0001421339 · EVP&Pres, Merck Animal Heallth

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,319

Underlying: Common Stock · 26,319 shares

Expires 2024-05-04

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

F2 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in one installment on 5/4/2024.

Read SEC document
May 03, 2021 Filed May 4, 2021 20:50 UTC
Karachun Rita ASr. VP Fince-Global Controller
Exercise / conversionRestricted Stock Unit · Derivative 875 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-015234 · form4.xml · derivative · entry 6

Karachun Rita A · CIK 0001601572 · Sr. VP Fince-Global Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 875

Underlying: Common Stock · 875 shares

Expires 2022-05-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

F4 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022.

Read SEC document
May 03, 2021 Filed May 4, 2021 20:50 UTC
Karachun Rita ASr. VP Fince-Global Controller
Tax withholdingCommon Stock 300 $74.50 $22,350.00
Disclosure

SEC source: 0001127602-21-015234 · form4.xml · nonDerivative · entry 4

Karachun Rita A · CIK 0001601572 · Sr. VP Fince-Global Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,002.972

F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
May 03, 2021 Filed May 4, 2021 20:50 UTC
Karachun Rita ASr. VP Fince-Global Controller
Exercise / conversionCommon Stock 875 $74.50 $65,187.50
Disclosure

SEC source: 0001127602-21-015234 · form4.xml · nonDerivative · entry 3

Karachun Rita A · CIK 0001601572 · Sr. VP Fince-Global Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,302.972

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 03, 2021 Filed May 4, 2021 20:55 UTC
Williams David MichaelEVP,Chief Info&Digital Officer
Exercise / conversionRestricted Stock Unit · Derivative 412 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-015251 · form4.xml · derivative · entry 6

Williams David Michael · CIK 0001820958 · EVP,Chief Info&Digital Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 414

Underlying: Common Stock · 412 shares

Expires 2022-05-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

F4 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022.

Read SEC document
May 03, 2021 Filed May 4, 2021 20:55 UTC
Williams David MichaelEVP,Chief Info&Digital Officer
Tax withholdingCommon Stock 142 $74.50 $10,579.00
Disclosure

SEC source: 0001127602-21-015251 · form4.xml · nonDerivative · entry 4

Williams David Michael · CIK 0001820958 · EVP,Chief Info&Digital Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,244.757

F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
May 03, 2021 Filed May 4, 2021 20:55 UTC
Williams David MichaelEVP,Chief Info&Digital Officer
Exercise / conversionCommon Stock 412 $74.50 $30,694.00
Disclosure

SEC source: 0001127602-21-015251 · form4.xml · nonDerivative · entry 3

Williams David Michael · CIK 0001820958 · EVP,Chief Info&Digital Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,386.757

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 03, 2021 Filed May 4, 2021 20:57 UTC
Li Dean YExecutive VP & President, MRL
Exercise / conversionRestricted Stock Unit · Derivative 750 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-015262 · form4.xml · derivative · entry 6

Li Dean Y · CIK 0001837016 · Executive VP & President, MRL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 750

Underlying: Common Stock · 750 shares

Expires 2022-05-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

F4 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022.

Read SEC document
May 03, 2021 Filed May 4, 2021 20:57 UTC
Li Dean YExecutive VP & President, MRL
Tax withholdingCommon Stock 257 $74.50 $19,146.50
Disclosure

SEC source: 0001127602-21-015262 · form4.xml · nonDerivative · entry 4

Li Dean Y · CIK 0001837016 · Executive VP & President, MRL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,853.914

F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
May 03, 2021 Filed May 4, 2021 20:57 UTC
Li Dean YExecutive VP & President, MRL
Exercise / conversionCommon Stock 750 $74.50 $55,875.00
Disclosure

SEC source: 0001127602-21-015262 · form4.xml · nonDerivative · entry 3

Li Dean Y · CIK 0001837016 · Executive VP & President, MRL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,110.914

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 03, 2021 Filed May 4, 2021 21:01 UTC Exercise / conversionRestricted Stock Unit · Derivative 750 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-015269 · form4.xml · derivative · entry 6

Litchfield Caroline · CIK 0001854928 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 750

Underlying: Common Stock · 750 shares

Expires 2022-05-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

F4 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022.

Read SEC document
May 03, 2021 Filed May 4, 2021 21:01 UTC Tax withholdingCommon Stock 353 $74.50 $26,298.50
Disclosure

SEC source: 0001127602-21-015269 · form4.xml · nonDerivative · entry 4

Litchfield Caroline · CIK 0001854928 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,191.1241

F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
May 03, 2021 Filed May 4, 2021 21:01 UTC Exercise / conversionCommon Stock 750 $74.50 $55,875.00
Disclosure

SEC source: 0001127602-21-015269 · form4.xml · nonDerivative · entry 3

Litchfield Caroline · CIK 0001854928 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,544.1241

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 03, 2021 Filed May 4, 2021 21:04 UTC
LeCointe-Cephas LisaSVP Chief Ethics & Com Officer
Exercise / conversionRestricted Stock Unit · Derivative 437 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-015279 · form4.xml · derivative · entry 6

LeCointe-Cephas Lisa · CIK 0001854644 · SVP Chief Ethics & Com Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 439

Underlying: Common Stock · 437 shares

Expires 2022-05-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

F4 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022.

Read SEC document
May 03, 2021 Filed May 4, 2021 21:04 UTC
LeCointe-Cephas LisaSVP Chief Ethics & Com Officer
Tax withholdingCommon Stock 150 $74.50 $11,175.00
Disclosure

SEC source: 0001127602-21-015279 · form4.xml · nonDerivative · entry 4

LeCointe-Cephas Lisa · CIK 0001854644 · SVP Chief Ethics & Com Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,918.346

F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
May 03, 2021 Filed May 4, 2021 21:04 UTC
LeCointe-Cephas LisaSVP Chief Ethics & Com Officer
Exercise / conversionCommon Stock 437 $74.50 $32,556.50
Disclosure

SEC source: 0001127602-21-015279 · form4.xml · nonDerivative · entry 3

LeCointe-Cephas Lisa · CIK 0001854644 · SVP Chief Ethics & Com Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,068.346

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 01, 2021 Filed May 4, 2021 20:50 UTC
Karachun Rita ASr. VP Fince-Global Controller
Exercise / conversionRestricted Stock Unit · Derivative 901 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-015234 · form4.xml · derivative · entry 5

Karachun Rita A · CIK 0001601572 · Sr. VP Fince-Global Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,803

Underlying: Common Stock · 901 shares

Expires 2023-05-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

F3 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023.

Read SEC document
May 01, 2021 Filed May 4, 2021 20:50 UTC
Karachun Rita ASr. VP Fince-Global Controller
Tax withholdingCommon Stock 309 $74.50 $23,020.50
Disclosure

SEC source: 0001127602-21-015234 · form4.xml · nonDerivative · entry 2

Karachun Rita A · CIK 0001601572 · Sr. VP Fince-Global Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,427.972

Read SEC document
May 01, 2021 Filed May 4, 2021 20:50 UTC
Karachun Rita ASr. VP Fince-Global Controller
Exercise / conversionCommon Stock 901 $74.50 $67,124.50
Disclosure

SEC source: 0001127602-21-015234 · form4.xml · nonDerivative · entry 1

Karachun Rita A · CIK 0001601572 · Sr. VP Fince-Global Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,736.972

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 01, 2021 Filed May 4, 2021 20:55 UTC
Williams David MichaelEVP,Chief Info&Digital Officer
Exercise / conversionRestricted Stock Unit · Derivative 560 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-015251 · form4.xml · derivative · entry 5

Williams David Michael · CIK 0001820958 · EVP,Chief Info&Digital Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,120

Underlying: Common Stock · 560 shares

Expires 2023-05-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

F3 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023.

Read SEC document
May 01, 2021 Filed May 4, 2021 20:55 UTC
Williams David MichaelEVP,Chief Info&Digital Officer
Tax withholdingCommon Stock 192 $74.50 $14,304.00
Disclosure

SEC source: 0001127602-21-015251 · form4.xml · nonDerivative · entry 2

Williams David Michael · CIK 0001820958 · EVP,Chief Info&Digital Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,974.757

Read SEC document
May 01, 2021 Filed May 4, 2021 20:55 UTC
Williams David MichaelEVP,Chief Info&Digital Officer
Exercise / conversionCommon Stock 560 $74.50 $41,720.00
Disclosure

SEC source: 0001127602-21-015251 · form4.xml · nonDerivative · entry 1

Williams David Michael · CIK 0001820958 · EVP,Chief Info&Digital Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,166.757

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 01, 2021 Filed May 4, 2021 20:57 UTC
Li Dean YExecutive VP & President, MRL
Exercise / conversionRestricted Stock Unit · Derivative 1,030 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-015262 · form4.xml · derivative · entry 5

Li Dean Y · CIK 0001837016 · Executive VP & President, MRL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,060

Underlying: Common Stock · 1,030 shares

Expires 2023-05-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

F3 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023.

Read SEC document
May 01, 2021 Filed May 4, 2021 20:57 UTC
Li Dean YExecutive VP & President, MRL
Tax withholdingCommon Stock 354 $74.50 $26,373.00
Disclosure

SEC source: 0001127602-21-015262 · form4.xml · nonDerivative · entry 2

Li Dean Y · CIK 0001837016 · Executive VP & President, MRL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,360.914

Read SEC document
May 01, 2021 Filed May 4, 2021 20:57 UTC
Li Dean YExecutive VP & President, MRL
Exercise / conversionCommon Stock 1,030 $74.50 $76,735.00
Disclosure

SEC source: 0001127602-21-015262 · form4.xml · nonDerivative · entry 1

Li Dean Y · CIK 0001837016 · Executive VP & President, MRL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,714.914

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 01, 2021 Filed May 4, 2021 21:01 UTC Exercise / conversionRestricted Stock Unit · Derivative 840 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-015269 · form4.xml · derivative · entry 5

Litchfield Caroline · CIK 0001854928 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,680

Underlying: Common Stock · 840 shares

Expires 2023-05-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

F3 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023.

Read SEC document
May 01, 2021 Filed May 4, 2021 21:01 UTC Tax withholdingCommon Stock 288 $74.50 $21,456.00
Disclosure

SEC source: 0001127602-21-015269 · form4.xml · nonDerivative · entry 2

Litchfield Caroline · CIK 0001854928 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,794.1241

Read SEC document
May 01, 2021 Filed May 4, 2021 21:01 UTC Exercise / conversionCommon Stock 840 $74.50 $62,580.00
Disclosure

SEC source: 0001127602-21-015269 · form4.xml · nonDerivative · entry 1

Litchfield Caroline · CIK 0001854928 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,082.1241

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 01, 2021 Filed May 4, 2021 21:04 UTC
LeCointe-Cephas LisaSVP Chief Ethics & Com Officer
Exercise / conversionRestricted Stock Unit · Derivative 622 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-015279 · form4.xml · derivative · entry 5

LeCointe-Cephas Lisa · CIK 0001854644 · SVP Chief Ethics & Com Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,245

Underlying: Common Stock · 622 shares

Expires 2023-05-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

F3 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.